Cargando…
An Assessment of Novel Biomarkers in Bone Metastatic Disease Using Multiplex Measurement and Multivariate Analysis
AIM: Current diagnostics of bone metastatic disease is not satisfactory for early detection or regular process monitoring. The combination of biomarkers and the multiparametric approach was described as effective in other oncology diagnoses. The aim of the study was to improve the difference diagnos...
Autores principales: | Windrichova, Jindra, Kucera, Radek, Fuchsova, Radka, Topolcan, Ondrej, Fiala, Ondrej, Svobodova, Jana, Finek, Jindrich, Slipkova, Dagmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198393/ https://www.ncbi.nlm.nih.gov/pubmed/30343636 http://dx.doi.org/10.1177/1533033818807466 |
Ejemplares similares
-
Comparison of four routinely used vitamin D automated immunoassays
por: Windrichova, Jindra, et al.
Publicado: (2021) -
Serum levels of markers in early detection of prostate cancer (pilote study)
por: Fuchsova, Radka, et al.
Publicado: (2014) -
The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line
por: Fiala, Ondrej, et al.
Publicado: (2018) -
The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6—A Study on 320 Patients After Radical Prostatectomy
por: Dolejsova, Olga, et al.
Publicado: (2018) -
The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases
por: Polivka, Jiri, et al.
Publicado: (2020)